Butamirate Mylan 1.7mg

Syrup

Composition :

BUTAMIRATE MYLAN GENERICS 2 mg / ml oral drops, solution: 1 ml of solution (equal to 20 drops) contains: active ingredient: 2 mg butamirate citrate (equivalent to 1.3 mg butamirate). BUTAMIRATE MYLAN GENERICS 1.7 mg / 5ml syrup: 100 ml of syrup contain: Active ingredient: Butamirate citrate 34.5 mg (equal to butamirate 21.3 mg).

Excipients

BUTAMIRATE MYLAN GENERICS 2 mg / ml oral drops, solution Citric acid, glycerol; 70% sorbitol; anethole; vanillin; methyl p-hydroxybenzoate; purified water. BUTAMIRATE MYLAN GENERICS 1,7 mg / 5ml citric acid syrup; glycerol; 70% sorbitol; vanillin; methyl p-hydroxybenzoate; purified water.

Therapeutic indications

Cough suppressant.

Contraindications

Hypersensitivity to components or strictly related substances from a chemical point of view. Pregnancy and lactation (see section 4.6). Children under the age of 2. The product contains sorbitol: therefore, it is contraindicated in cases of hereditary fructose intolerance

Dosage

BUTAMIRATE MYLAN GENERICS 2 mg / ml oral drops, solution Children 2-5 years: 15 drops every 8-6 hours. School-age children (6-12 years): 20 drops every 8-6 hours. Adults: 40 drops every 6-5 hours. BUTAMIRATE MYLAN GENERICS 1.7 mg / 5ml syrup Children of 2-6 years: 5 ml every 8-6 hours. School-age children (6-12 years): 10 ml every 8-6 hours. Adults: 15 ml every 8-6 hours. Do not exceed the recommended dose.

Warnings and Precautions

In subjects suffering from severe renal and / or hepatic insufficiency BUTAMIRATE MYLAN GENERICS should be administered only in case of real need and under the direct supervision of the doctor, taking into account that the effective plasma rates of butamirate citrate may be higher and / or longer lasting. than in subjects with normal hepatic and / or renal function. The product contains glycerol: it can be dangerous in high doses; it can cause migraines, stomach problems and diarrhea. The product contains sorbitol which can cause gastric problems and diarrhea. The product contains parahydroxybenzoate which can cause delayed allergic reactions such as contact dermatitis; more rarely it can cause immediate reactions with urticaria and bronchospasm.

Interactions

None known so far.

Side effects

The tolerability of BUTAMIRATO MYLAN GENERICS is good. In rare cases, nausea, anorexia, transient gastric disturbances (diarrhea), skin rash, dizziness have been reported. These effects disappear following a reduction in the dosage or discontinuation of the drug.

Pregnancy and breastfeeding

BUTAMIRATE MYLAN GENERICS should not be used during pregnancy and lactation. Its use should also be avoided in cases of suspected pregnancy or when you want to plan a maternity leave.